The EU's generic drug market is shaped by four approval pathways, each with different timelines and costs. The 2025 Pharma Package reforms are accelerating market entry, but national inconsistencies still delay access for patients across Europe.
Read More
How to Keep a Symptom Diary for Suspected Drug Reactions
Opioids During Pregnancy: Risks, Withdrawal, and Monitoring
Best and Worst Foods for Menopause Relief: Your Essential Diet Guide
Palliative and Hospice Care: Balancing Symptom Control and Side Effects
Clotrimazole vs Nystatin: Cost, Cure Rates & What Works Best for Diaper Rash
